GJB6

Chr 13ADARDigenic dominant

gap junction protein beta 6

Also known as: CX30, DFNA3, DFNA3B, DFNB1B, ECTD2, ED2, EDH, HED

GJB6 encodes connexin-30, a gap junction protein that forms transmembrane channels allowing small molecules and ions to pass between adjacent cells. Mutations cause autosomal recessive or dominant nonsyndromic hearing loss and hidrotic ectodermal dysplasia, a condition affecting hair, nails, teeth, and sweat glands. This gene is not highly constrained against loss-of-function variants.

GeneReviewsOMIMResearchSummary from RefSeq, UniProt
LOFmechanismAD/AR/Digenic dominantLOEUF 1.744 OMIM phenotypes
Clinical SummaryGJB6
🧬
Gene-Disease Validity (ClinGen)
nonsyndromic genetic hearing loss · ARRefuted

Refuted — evidence has disproved this relationship

2 total gene-disease associations curated

Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📖
GeneReview available — GJB6
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
1.74LOEUF
pLI 0.000
Z-score -0.21
OE 1.07 (0.661.74)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint
0.45Z-score
OE missense 0.90 (0.781.03)
134 obs / 149.6 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE1.07 (0.661.74)
00.351.4
Missense OE0.90 (0.781.03)
00.61.4
Synonymous OE1.08
01.21.6
LoF obs/exp: 10 / 9.3Missense obs/exp: 134 / 149.6Syn Z: -0.49
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
limitedGJB6-related deafnessLOFAR
definitiveGJB6-related ectodermal dysplasia, Clouston typeOTHERAD
DN
0.80top 10%
GOF
0.86top 5%
LOF
0.2288th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median · 1 literature citation
DNprediction above median · 1 literature citation

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Literature Evidence

DNT5MCX30 suppressed the wild-type transjunctional conductance in a dominant-negative manner (Fig. 2b,c), resulting in inhibition of intercellular coupling.PMID:10471490
GOFA gain of function was observed for G11R and A88V CX30, which formed functional hemichannels at the cell surface and, when expressed in HeLa cells, generated a leakage of ATP into the extracellular medium.PMID:15213106

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

GJB6 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →